Endogenous versus exogenous cell replacement for Parkinson’s disease: where are we at and where are we going?

Endogenous versus exogenous cell replacement for Parkinson’s disease: where are we at and where are we going?

Parkinson’s disease is the second most common neurodegenerative disease and has currently no effective treatment, one that would be able to stop or reverse the loss of dopaminergic neurons in the substantia nigra pars compacta. In addition, Parkinson’s disease diagnosis is typically done when a sign...

Full description

Bibliographic Details
Main Authors:	Theodora Mourtzi, Ilias Kazanis
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2022-01-01
Series:	Neural Regeneration Research
Subjects:	endogenous; neurodegenerative disease; neurogenesis; neurotrophic factors; parkinson’s disease; stem cells; transdifferentiation; transplantations
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2022;volume=17;issue=12;spage=2637;epage=2642;aulast=Mourtzi

Similar Items

Enhancement of endogenous midbrain neurogenesis by microneurotrophin BNN-20 after neural progenitor grafting in a mouse model of nigral degeneration
by: Theodora Mourtzi, et al.
Published: (2024-01-01)

Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease
by: Paulina Troncoso-Escudero, et al.
Published: (2018-10-01)

Dermatology: Where Are We Coming from and Where Are We Going To?
by: Peter van de Kerkhof
Published: (2014-10-01)

Breast Implant Illness: where are we and where are we going?
by: Ricardo Votto, et al.
Published: (2022-03-01)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
by: Melissa J. Alldred, et al.
Published: (2021-10-01)

Deep brain stimulation for Parkinson’s disease: where do we stand?
by: Alberto eAlbanese, et al.
Published: (2011-05-01)

SARS-CoV-2 and Parkinson’s Disease: A Review of Where We Are Now
by: Iro Boura, et al.
Published: (2023-09-01)

Tofacitinib and newer JAK inhibitors in inflammatory bowel disease—where we are and where we are going
by: Eleanor Liu, et al.
Published: (2022-04-01)

Botanica. Where are we, and where are we going?
by: Zigmantas Gudžinskas
Published: (2022-06-01)

Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson’s Disease
by: Cang Chen, et al.
Published: (2020-06-01)

Alcoholic hepatitis: How far are we and where are we going?
by: Verónica Prado, et al.
Published: (2016-07-01)

Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going?
by: Iago José da Silva Domingos, et al.
Published: (2021-03-01)

Overactive Bladder: Where We Are and Where We Are Going
by: Charan S. Mohan, et al.
Published: (2021-09-01)

Where We Are and Where We Are Going in Nut Research
by: Jordi Salas-Salvadó, et al.
Published: (2023-03-01)

COVID-19: Where We Are and Where We Are Going
by: Ludovico Abenavoli, et al.
Published: (2023-03-01)

Hidradenitis Suppurativa: Where We Are and Where We Are Going
by: Emanuele Scala, et al.
Published: (2021-08-01)

Bioactive Glasses: Where Are We and Where Are We Going?
by: Francesco Baino, et al.
Published: (2018-03-01)

CCDs and WET: where are we and where are we going
by: O’Donoghue D., et al.
Published: (2000-09-01)

Iron health: where are we and where are we going?
by: Glória Ines Beal Gotardo
Published: (2011-06-01)

Gravitational waves: where we are, where we go
by: Ricci Fulvio
Published: (2019-01-01)

Obstetric ultrasound: where are we and where are we going?
by: Jacques S Abramowicz
Published: (2021-01-01)

Neurotoxicity and Underlying Mechanisms of Endogenous Neurotoxins
by: Yanlu Cao, et al.
Published: (2021-11-01)

Neural pericytes: A genomic archival state programmed by CHromatin topology
by: Ramin M. Farahani
Published: (2022-04-01)

Evolving Indications of Transcatheter Aortic Valve Replacement—Where Are We Now, and Where Are We Going
by: Jules Mesnier, et al.
Published: (2022-05-01)

Protein and Gene Delivery Systems for Neurodegenerative Disorders: Where Do We Stand Today?
by: Panoraia I. Siafaka, et al.
Published: (2022-11-01)

Characterization of substantia nigra neurogenesis in homeostasis and dopaminergic degeneration: beneficial effects of the microneurotrophin BNN-20
by: Theodora Mourtzi, et al.
Published: (2021-06-01)

Artificial Intelligence-Based Management of Adult Chronic Myeloid Leukemia: Where Are We and Where Are We Going?
by: Simona Bernardi, et al.
Published: (2024-02-01)

The gut microbiome in human health and disease—Where are we and where are we going? A bibliometric analysis
by: Zhiqiang Huang, et al.
Published: (2022-12-01)

Targeting Oxidative Stress for Disease Prevention and Therapy: Where Do We Stand, and Where Do We Go from Here
by: Cristina Vassalle, et al.
Published: (2020-06-01)

Mathematics anxiety—where are we and where shall we go?
by: Cipora, K, et al.
Published: (2022)

Biomarkers of Neonatal Sepsis: Where We Are and Where We Are Going
by: Giovanni Boscarino, et al.
Published: (2023-07-01)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
by: Michał P. Wasilewicz, et al.
Published: (2023-04-01)

Osteoarthritis and Diabetes: Where Are We and Where Should We Go?
by: Aqeel M. Alenazi, et al.
Published: (2023-04-01)

Colon Capsule Endoscopy: Where Are We and Where Are We Going
by: Yoo Min Han, et al.
Published: (2016-09-01)

Chronic Pulmonary Aspergillosis—Where Are We? and Where Are We Going?
by: Gemma E. Hayes, et al.
Published: (2016-06-01)

Gastroenterology and hepatology in Croatia – where are we and where are we going?
by: Neven Ljubičić, et al.
Published: (2021-01-01)

NISQ computing: where are we and where do we go?
by: Jonathan Wei Zhong Lau, et al.
Published: (2022-09-01)

Accommodative intraocular lenses: where are we and where we are going
by: Jorge L. Alió, et al.
Published: (2017-06-01)

Research in defense logistics: where are we and where are we going?
by: George A. Zsidisin, et al.
Published: (2020-01-01)

Pediatric Sepsis Research: Where Are We and Where Are We Going?
by: Letícia Massaud-Ribeiro, et al.
Published: (2022-02-01)